Witness a Walgreens truck cruising through the bustling streets of Manhattan, New York City, showcasing the power of Walgreens Boots Alliance on Nov. 26, 2021.
In an exciting development, Walgreens announced its direct collaboration with drugmakers to introduce cutting-edge cell and gene therapies to American patients. This initiative marks a significant expansion of its specialty pharmacy services.
A dedicated business unit focused on the specialty pharmacy segment, including the subsidiary AllianceRx, is set to launch under the umbrella of Walgreens’ core U.S. retail pharmacy division. Meanwhile, Shields Health Solutions, a subsidiary supporting health system-owned specialty pharmacies, will continue to operate under Walgreens’s U.S. health-care division.
Specialty pharmacies play a crucial role in the U.S. healthcare landscape, particularly with the rise of chronic diseases. These pharmacies handle, store, and distribute medications that require meticulous care.
Experience the future of healthcare with Walgreens as they pave the way for innovative cell and gene therapies in the U.S. market.
2024-04-24 23:01:01
Source from www.cnbc.com
